MT-701 for Safety Evaluation in Healthy Subjects
What You Need to Know Before You Apply
What is the purpose of this trial?
First-in-human study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple doses of MT-701 in healthy participants.
Are You a Good Fit for This Trial?
This trial is for healthy adults aged 19-55 who can consent to study requirements. Women must be unable to bear children, either postmenopausal or surgically sterile with documentation. Men should use effective contraception during the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Single Ascending Dose
Participants receive a single intravenous/subcutaneous dose of MT-701 to assess safety and tolerability
Multiple Ascending Dose
Participants receive multiple intravenous/subcutaneous doses of MT-701 to assess safety and tolerability
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- MT-701
Trial Overview
The trial tests MT-701's safety and how it affects the body (pharmacokinetics) in single and multiple doses on healthy people. It also checks if the body creates any immune response against MT-701.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
To assess the safety and tolerability of multiple intravenous/subcutaneous doses of MT-701.
To assess the safety and tolerability of single intravenous/subcutaneous dose of MT-701.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mirador Therapeutics, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.